A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells
about
Non-canonical signaling mode of the epidermal growth factor receptor familyMSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCsEpidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.Epidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysPrediction of oncogenic interactions and cancer-related signaling networks based on network topology.Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo.Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systemsNuclear localization of lymphocyte-specific protein tyrosine kinase (Lck) and its role in regulating LIM domain only 2 (Lmo2) gene.Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locationsThe nuclear epidermal growth factor receptor signaling network and its role in cancer.A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer.Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor.Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor familyIGFBP2 potentiates nuclear EGFR-STAT3 signaling.STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3DNA-Directed Assembly of Nanogold Dimers: A Unique Dynamic Light Scattering Sensing Probe for Transcription Factor Detection.Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo.Steroid-like signalling by interferons: making sense of specific gene activation by cytokines.Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways.Access to the nucleus and functional association with c-Myc is required for the full oncogenic potential of ΔEGFR/EGFRvIIIA molecular case report: functional assay of tyrosine kinase inhibitors in cells from a patient's primary renal cell carcinoma.Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.EGFR and HER2 signaling in breast cancer brain metastasis.Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1.Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer.Resveratrol mediates cell cycle arrest and cell death in human esophageal squamous cell carcinoma by directly targeting the EGFR signaling pathway.Nuclear EGFR as a molecular target in cancer.EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2.EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.Selective Inhibition of STAT3 Phosphorylation Using a Nuclear-Targeted Kinase Inhibitor.Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival.Developing a nanoparticle test for prostate cancer scoring.IFN signaling: how a non-canonical model led to the development of IFN mimetics.Hepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF/c-Met/Akt and Jak2/Stat3 pathwaysA facile nanoparticle immunoassay for cancer biomarker discovery.Src nuclear localization and its prognostic relevance in human osteosarcoma.
P2860
Q26773754-5B3BF188-4065-480A-AE97-CAA0C89C7435Q28484364-4B1733D1-40DA-4471-9A0E-E28D36F9B21CQ30571353-33E0A57E-F87A-48B9-9CCD-198A61D7DA77Q33711342-87034E7F-B5C3-4DE6-9E4E-3B88E3CDB4E2Q33737298-016ACE91-E6F0-427E-8E01-3BD98387D3A1Q35035344-A00E4F43-AC35-4670-8F11-CAA202CBDB80Q35152542-E7AD1E30-293B-42C8-802A-6778F738C89CQ35640830-E05F55D6-29E8-48B8-A347-812708DAFFEEQ35690778-0E3ED58F-30C5-4DA3-A2C1-DE7F6B7C1185Q35831012-0FFAC089-3F4D-47EC-A9FF-09F50858A945Q35834849-830F187D-D322-4F11-8A17-A6B78C64F833Q35875878-EFE7E377-063B-4615-9B35-10A9ACA40163Q36054625-3B1A2157-09A3-4B81-B458-64911B17D950Q36113481-47567968-7832-4590-9215-21B698AD3C29Q36162605-9109DA3D-9377-4AB1-B29C-3292A390D100Q36189855-E2D4BEFC-3AB3-436E-858D-392ACDC5B7DBQ36351195-A6A77056-D568-42CB-A7E9-C30A71780BFCQ36382314-884D388E-B29B-4716-9A06-0474AE12222EQ36385313-E189609E-669B-497A-8DA1-632F406FDE18Q36431134-5512F1D8-9EED-4714-A143-FA7759DE9DDBQ36466176-5C09EE66-9AB9-4BD9-91B2-4A52E4B073B5Q36579570-6C758FD2-3E96-42F1-B04F-5AA653DDEC16Q36608758-1AF25B1F-03EC-4F6F-97FB-B960D6CDAD33Q36617162-48628D2C-3559-4E62-B41E-45B3F164E609Q36733618-8802A703-982C-4D8B-A314-FEF5825D6013Q36879506-47E8BF72-E330-4149-8444-8E234E934001Q37007828-167EDAA9-663F-49A2-836C-EC5D578D4111Q37448070-B2BA57F0-F637-46C5-A7C1-3CE0EE8413DAQ37594225-F2DDD60E-18DC-4E46-A63F-1137219C7270Q38119635-78A4A9D7-07AE-410A-B2C2-44DAA1E392C2Q38199643-DA879F7D-9062-4BE5-9048-69779C2967FFQ38244150-2D7DED5A-8A9C-4612-A838-F4BFDD346590Q38552978-802CA68D-DEF7-433C-B3EC-970D5CE49D97Q38634605-B598ECD3-3A5D-4F16-A8C8-2BF60840A233Q38810432-5C1D63B4-FD33-4651-9F16-D173983A1209Q41900218-0B0EB7D3-1943-4C80-AB4A-0D4C5DBE2386Q42049778-FAB6D196-F5BE-47FE-9F9E-27830E6A6764Q42181154-61DB4BD6-2473-46E7-963F-CD5226952B4FQ42782910-C67E62DC-2E22-48C5-9D77-CA1F371D5877Q47965081-B374989E-2F6A-40F6-B7C6-8EEB0C0426EC
P2860
A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A functional nuclear epidermal ...... lex in pancreatic cancer cells
@ast
A functional nuclear epidermal ...... lex in pancreatic cancer cells
@en
type
label
A functional nuclear epidermal ...... lex in pancreatic cancer cells
@ast
A functional nuclear epidermal ...... lex in pancreatic cancer cells
@en
prefLabel
A functional nuclear epidermal ...... lex in pancreatic cancer cells
@ast
A functional nuclear epidermal ...... lex in pancreatic cancer cells
@en
P2093
P2860
P1433
P1476
A functional nuclear epidermal ...... lex in pancreatic cancer cells
@en
P2093
David C Paladino
James Turkson
Jelena Bogdanovic
Peibin Yue
Soumya Jaganathan
P2860
P304
P356
10.1371/JOURNAL.PONE.0019605
P407
P577
2011-05-05T00:00:00Z